These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 26936972)

  • 1. Evaluating the Disposition of a Mixed Aldehyde Oxidase/Cytochrome P450 Substrate in Rats with Attenuated P450 Activity.
    Crouch RD; Morrison RD; Byers FW; Lindsley CW; Emmitte KA; Daniels JS
    Drug Metab Dispos; 2016 Aug; 44(8):1296-303. PubMed ID: 26936972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of aldehyde oxidase and xanthine oxidase in the biotransformation of a novel negative allosteric modulator of metabotropic glutamate receptor subtype 5.
    Morrison RD; Blobaum AL; Byers FW; Santomango TS; Bridges TM; Stec D; Brewer KA; Sanchez-Ponce R; Corlew MM; Rush R; Felts AS; Manka J; Bates BS; Venable DF; Rodriguez AL; Jones CK; Niswender CM; Conn PJ; Lindsley CW; Emmitte KA; Daniels JS
    Drug Metab Dispos; 2012 Sep; 40(9):1834-45. PubMed ID: 22711749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of species differences in the metabolism of the selective Na
    Asano D; Shibayama T; Shiozawa H; Inoue SI; Shinozuka T; Murata S; Watanabe N; Yoshinari K
    Xenobiotica; 2021 Sep; 51(9):1060-1070. PubMed ID: 34330191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of the cytochrome P450 mechanism-based inhibitor N-benzyl-1-aminobenzotriazole to products that covalently bind with protein in guinea pig liver and lung microsomes: comparative study with 1-aminobenzotriazole.
    Woodcroft KJ; Webb CD; Yao M; Weedon AC; Bend JR
    Chem Res Toxicol; 1997 May; 10(5):589-99. PubMed ID: 9168258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Cytochrome P450 Selectivity for Hydralazine as an Aldehyde Oxidase Inhibitor for Reaction Phenotyping.
    Yang X; Johnson N; Di L
    J Pharm Sci; 2019 Apr; 108(4):1627-1630. PubMed ID: 30448524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo use of the P450 inactivator 1-aminobenzotriazole in the rat: varied dosing route to elucidate gut and liver contributions to first-pass and systemic clearance.
    Strelevitz TJ; Foti RS; Fisher MB
    J Pharm Sci; 2006 Jun; 95(6):1334-41. PubMed ID: 16625658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro Metabolism by Aldehyde Oxidase Leads to Poor Pharmacokinetic Profile in Rats for c-Met Inhibitor MET401.
    Zhang JW; Deng HB; Zhang CY; Dai JQ; Li Q; Zheng QG; Wan HX; Yu HP; He F; Xu YC; Zhao S; Zhang JYJ
    Eur J Drug Metab Pharmacokinet; 2019 Oct; 44(5):669-680. PubMed ID: 31030415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydralazine as a selective probe inactivator of aldehyde oxidase in human hepatocytes: estimation of the contribution of aldehyde oxidase to metabolic clearance.
    Strelevitz TJ; Orozco CC; Obach RS
    Drug Metab Dispos; 2012 Jul; 40(7):1441-8. PubMed ID: 22522748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pretreatment regimens of 1-aminobenzotriazole on metabolism and gastric emptying of probe compounds in rat.
    Padmanabhan S; Kaur H; Rao A; Saxena A; Gupta YK; Mariappan TT; Holenarsipur VK
    Xenobiotica; 2019 Jun; 49(6):646-654. PubMed ID: 29898636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-Aminobenzotriazole, a known cytochrome P450 inhibitor, is a substrate and inhibitor of N-acetyltransferase.
    Sun Q; Harper TW; Dierks EA; Zhang L; Chang S; Rodrigues AD; Marathe P
    Drug Metab Dispos; 2011 Sep; 39(9):1674-9. PubMed ID: 21677062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP2C8-Mediated Formation of a Human Disproportionate Metabolite of the Selective Na
    Asano D; Hamaue S; Zahir H; Shiozawa H; Nishiya Y; Kimura T; Kazui M; Yamamura N; Ikeguchi M; Shibayama T; Inoue SI; Shinozuka T; Watanabe T; Yahara C; Watanabe N; Yoshinari K
    Drug Metab Dispos; 2022 Mar; 50(3):235-242. PubMed ID: 34930785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atipamezole is a promising non-discriminative inhibitor against pan-CYP450 including diclofenac 4'-hydroxylation: A comparison with ABT for drug ADME optimization and mechanism study.
    Li Z; Zhang Y; Gao Y; Xiang Y; Zhang W; Lu C; Zhuang X
    Eur J Pharm Sci; 2019 Mar; 130():156-165. PubMed ID: 30690186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methoxsalen as an in vitro phenotyping tool in comparison with 1-aminobenzotriazole.
    Palacharla RC; Molgara P; Panthangi HR; Boggavarapu RK; Manoharan AK; Ponnamaneni RK; Ajjala DR; Nirogi R
    Xenobiotica; 2019 Feb; 49(2):169-176. PubMed ID: 29382249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species-Specific Involvement of Aldehyde Oxidase and Xanthine Oxidase in the Metabolism of the Pyrimidine-Containing mGlu
    Crouch RD; Blobaum AL; Felts AS; Conn PJ; Lindsley CW
    Drug Metab Dispos; 2017 Dec; 45(12):1245-1259. PubMed ID: 28939686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-Aminobenzotriazole modulates oral drug pharmacokinetics through cytochrome P450 inhibition and delay of gastric emptying in rats.
    Stringer RA; Weber E; Tigani B; Lavan P; Medhurst S; Sohal B
    Drug Metab Dispos; 2014 Jul; 42(7):1117-24. PubMed ID: 24727486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of food pellets containing 1-aminobenzotriazole for longer term in vivo inhibition of cytochrome P450 in mice.
    Stringer R; Cordier V; Afatsawo C; Arabin P; Desrayaud S; Hoffmann L; Lehmann D; Lowe PJ; Risser F; Thiel J; Widmer T; Wipfli P; Bigaud M
    Xenobiotica; 2019 Jan; 49(1):13-21. PubMed ID: 29299977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case Study 11: Considerations for Enzyme Mapping Experiments-Interaction Between the Aldehyde Oxidase Inhibitor Hydralazine and Glutathione.
    Crouch RD; Beers JL; Jackson KD
    Methods Mol Biol; 2021; 2342():809-823. PubMed ID: 34272718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case report of extensive metabolism by aldehyde oxidase in humans: pharmacokinetics and metabolite profile of FK3453 in rats, dogs, and humans.
    Akabane T; Tanaka K; Irie M; Terashita S; Teramura T
    Xenobiotica; 2011 May; 41(5):372-84. PubMed ID: 21385103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro and In Vivo Correlation of Hepatic Fraction of Metabolism by P450 in Dogs.
    Zhou X; Hui YH; Hudson L; Katyayan KK; Mohutsky MA; Hao J; Schober DA; Hembre EJ
    J Pharm Sci; 2019 Feb; 108(2):1017-1026. PubMed ID: 30244007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of Osmotic Pumps for Sustained Release of 1-Aminobenzotriazole and Inhibition of Cytochrome P450 Enzymes in Mice: Model Comparison with the Hepatic P450 Reductase Null Mouse.
    Stringer RA; Ferreira S; Rose J; Ronseaux S
    Drug Metab Dispos; 2016 Aug; 44(8):1213-6. PubMed ID: 27271368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.